Lithium diisopropylamide

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Lithium diisopropylamide
Image:Dimerliamide.jpg
IUPAC name Lithium diisopropylamide
Other names LDA
Identifiers
CAS number 4111-54-0
Properties
Molecular formula C6H14LiN or LiN(C3H7)2
Molar mass 107.1233 g/mol
Density 0.79 g/cm³, ?
Melting point

°C (? K)

Boiling point

(? K)

Solubility in water Reacts with water
Acidity (pKa) 34
Viscosity  ? cP at ?°C
Hazards
Main hazards corrosive
Flash point  ?°C
Related Compounds
Related compounds Superacids
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

Lithium diisopropylamide is the chemical compound with the formula [(CH3)2CH]2NLi. Generally abbreviated LDA, it is a strong base, used in organic chemistry for the deprotonation of hydrocarbons. The reagent has been widely accepted because it is soluble in non-polar organic solvents and it is non-pyrophoric. LDA is a non-nucleophilic base.

Contents

Preparation and structure

LDA is formed by treating a cooled (0 to -78 °C) THF solution of diisopropylamine with n-butyllithium. Diisopropylamine has pKa value of 36; therefore, it is suitable for the deprotonation of most common carbon acids including alcohols and carbonyl compounds (acids, esters, aldehydes and ketones) possessing an alpha carbon with hydrogens. In THF solution, LDA exists primarily as a dimer[1][1] and is proposed to dissociate to afford the active base.

LDA is commercially available as a solution with polar, aprotic solvents such as THF and ether, though in practice and for small scale use (less than 50 mmol) it is common (and actually more cost effective) to prepare LDA in situ.

Kinetic vs thermodynamic bases

The deprotonations of carbon acids can proceed with either kinetic or thermodynamic reaction control. Kinetic controlled deprotonation requires a base that is sterically hindered. For example in the case of phenylacetone, deprotonation can produce two different enolates. LDA has been shown to deprotonate the methyl group, which is the kinetic course of the deprotonation. A weaker base such as an alkoxide, which reversibly deprotonates the substrate, affords the more thermodynamically stable benzylic enolate. An alternative to the weaker base is to use a strong base which is present at a lower concentration than the ketone. For instance a slurry of sodium hydride in THF or DMF, the base only reacts at the solution-solid interface. It is the case that a ketone molecule might deprotonate at the kinetic site, this enolate will then encounter other ketone molecules. The thermodynamic enolate will form through the exchange of protons, even in an aprotic solvent which does not contain hydronium ions.

It is important to note that LDA can still act as a nucleophile, for instance it can react with tungsten hexacarbonyl as part of the synthesis of a diisopropylaminocarbyne.[citation needed] If given the proper conditions, LDA will act like any other nucleophile and perform condensation reactions. Other even more hindered amide bases are known, for instance the deprotonation of hexamethyldisilazane (Me3SiNHSiMe3) forms such a base ([(Me3SiNSiMe3]-).

References


Further reading

fr:Diisopropylamidure de lithium ja:リチウムジイソプロピルアミド sv:Litiumdiisopropylamid


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
related articles
viewed previously [ + ]